RECRUITING

Radiofrequency Ablation for BIII Thyroid Nodules

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this observational chart review study is to evaluate the efficacy and safety of Radiofrequency Ablation (RFA) for treatment of indeterminate thyroid nodules before and after RFA procedure. This is a data collection study in which the investigators ask patients to give access to information generated before and after RFA treatment of their condition. The RFA procedure uses image guidance to place an electrode through the skin into the target area. In RFA, high-frequency electrical currents are passed through an electrode, creating a small region of heat to treat the lesion.

Official Title

Radiofrequency Ablation for Indeterminate Bethesda III Thyroid Nodules

Quick Facts

Study Start:2020-08-01
Study Completion:2026-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05189808

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Indeterminate Bethesda III nodules that have been molecularly profiled benign with either Afirma Genomic Sequencing Classifier (GSC) or ThyroSeq v3 tests
  1. * cardiac arrthymias
  2. * pregnancy

Contacts and Locations

Study Contact

Jennifer H Kuo, MD MS
CONTACT
212-305-6969
jhk2029@cumc.columbia.edu
Catherine McManus, MD MS
CONTACT
212-305-6969
cm3304@cumc.columbia.edu

Principal Investigator

Jennifer H Kuo, MD MS
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Columbia University
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Jennifer H Kuo, MD MS, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-08-01
Study Completion Date2026-08

Study Record Updates

Study Start Date2020-08-01
Study Completion Date2026-08

Terms related to this study

Keywords Provided by Researchers

  • Radiofrequency Ablation

Additional Relevant MeSH Terms

  • Indeterminate Bethesda III Thyroid Nodules